Medtronic received information via literature regarding aortic root replacement in octogenarians offers acceptable perioperative and late outcomes.All data were collected from a single center between 2005 and 2012.The study population included 592 patients (predominantly male, mean age 58 years for the less than 80 group and mean age of 83 for the over 80 group), 214 of which were implanted with medtronic 3f (serial numbers not provided).Among all patients 15 deaths occurred.Based on the available information, none of the deaths were attributed to medtronic product.Among all patients adverse events included: bleeding, stroke, new need for renal therapy, myocardial infarction, atrial fibrillation, new pacemaker placement, reoperations.Based on the available information, these adverse events may have been attributed to medtronic product.
|